234 filings
Page 5 of 12
8-K
rv260g
29 Mar 18
Results of Operations and Financial Condition
12:00am
8-K
ciyxlqaa
23 Mar 18
Casi Pharmaceuticals Announces $50 Million Private Placement to Prepare Company for Commercialization In China
12:00am
8-K
vszp79wwf w2r
16 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
lmp 8js2hspr2wnc
23 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
meczv 1j3imx38
9 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
i45pf2 es8cqc
26 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
1oo 2b5hgsefq3qbh6qc
22 Dec 17
Entry into a Material Definitive Agreement
12:00am
8-K
fgvdn1wm4 bnqy95
8 Dec 17
Departure of Directors or Certain Officers
12:00am
8-K
48c 5okpqtm8kq
14 Nov 17
Casi Pharmaceuticals Reports Third Quarter 2017 Financial Results
12:00am
8-K
ms2tozmp888 a6j1y
19 Oct 17
Casi Pharmaceuticals Announces $23.8 Million Registered Direct Offering Led by Existing Shareholders
12:00am
8-K
rzt4ys5i6o
7 Sep 17
Casi Provides Pipeline Development Update
12:00am
8-K
9wf8z56c0v iqz6mj
14 Aug 17
Casi Pharmaceuticals Reports Second Quarter 2017 Financial Results
12:00am
8-K
8z8 8ugcedcvw7w81
9 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
fxvsqf
15 May 17
Casi Pharmaceuticals Reports First Quarter 2017 Financial Results
12:00am
8-K
u0bk6r0km3zrpc0
31 Mar 17
Casi Pharmaceuticals Reports 2016 Fourth Quarter and Full Year Financial Results
12:00am
8-K
fj3f8th9
16 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
li4q wup4g141v4v7
14 Nov 16
Casi Pharmaceuticals Reports Third Quarter 2016 Financial Results
12:00am
8-K
nx0mqi
25 Oct 16
Entry into a Material Definitive Agreement
12:00am
8-K
kdh7eavd6 1jk
5 Oct 16
Unregistered Sales of Equity Securities
12:00am
8-K
w6np4 d8l1k77
15 Aug 16
Casi Pharmaceuticals Reports Second Quarter 2016 Financial Results
12:00am